Vigabatrin but not valproate prevents development of age-specific flexion seizures induced by N-methyl-D-aspartate (NMDA) in immature rats

Epilepsia

Volumn 51, Issue 3, 2010, Pages 469-472

  Kubová, Hana ^a   Mareš, Pavel ^a  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

Flexion seizures; Immature rats; N methyl D aspartate; Valproate; Vigabatrin

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID; VALPROIC ACID; VIGABATRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLONIC SEIZURE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; INFANTILE SPASM; MORTALITY; NEWBORN; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; RAT; TONIC CLONIC SEIZURE; WEIGHT REDUCTION;

AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; ANTICONVULSANTS; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; EPILEPSY, TONIC-CLONIC; HUMANS; INFANT; N-METHYLASPARTATE; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; SEIZURES; SPASMS, INFANTILE; VALPROIC ACID; VIGABATRIN;

EID: 77749251921     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2009.02305.x     Document Type: Article

References (13)

1. Haugvicová R, Kubová H, Mareš P. (2002) Does vigabatrin possess an anticonvulsant action against pentylenetetrazol-induced seizures in developing rats? Physiol Res 51:363-370.
2. Kábová R, Liptáková S, Š lamberová R, Pometlová M, Velíšek L. (1999) Age-specific N-methyl-D-aspartate-induced seizures: perspectives for the West syndrome model. Epilepsia 40:1357-1369.
3. Kubová H, Mareš P. (1992) The effect of ontogenetic development on the anticonvulsant activity of midazolam. Life Sci 50:1665-1672.
4. Kubová H, Folbergrová J, Mareš P. (1995) Seizures induced by homocysteine in rats during ontogenesis. Epilepsia 36:750-756.
5. Lux AL, Edwards SW, Hancock E, Johnson AL, Kennedy CR, Newton RW, O'Callaghan FJ, Verity CM, Osborne JP. (2005) The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial. Lancet Neurol 4:712-717.
6. Mareš P, Marešová D, Schickerová R. (1981) Effect of antiepileptic drugs on Metrazol convulsions during ontogenesis in the rat. Physiol Bohemoslov 30:113-121.
7. Mareš P, Velíšek L. (1987) Comparison of antiepileptic action of valproate and ethosuximide in adult and immature rats. Pol J Pharmacol Pharm 39:505-512.
8. Mareš P, Velíšek L. (1992) N-Methyl-D- aspartate (NMDA)-induced seizures in developing rats. Brain Res Dev Brain Res 65:185-189.
9. Mareš P, Folbergrová J, Langmeier M, Haugvicová R, Kubová H. (1997) Convulsant action of D,L-homocysteic acid and its stereoisomers in immature rats. Epilepsia 38:767-776.
10. Nabbout R. (2001) A risk-benefit assessment of treatments for infantile spasms. Drug Saf 24:813-828.
11. Stafstrom CE, Moshé SL, Swann JW, Nehlig A, Jacobs MP, Schwartzkroin PA. (2006) Models of pediatric epilepsies: strategies and opportunities. Epilepsia 47:1407-1414.
12. Velíšek L, Mareš P. (1995) Age-dependent anticonvulsant action of clonazepam in the N-methyl-D-aspartate model of seizures. Pharmacol Biochem Behav 52:291-296.
13. Velíšek L, Jehle K, Asche S, Velíšková J. (2007) Model of infantile spasms induced by N-methyl-D-aspartic acid in prenatally impaired brain. Ann Neurol 61:109-119.